InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2024

Published on September 10, 2024

DENVER, Sept. 10, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE),

Continue reading on website
Other news

Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates

September 10, 2024
New assays based on iPSC help accelerate drug discovery by giving drug innovators in neurodegenerative diseases high quality data on a broad range of disease-relevant read-outs

5 Must-Dos to Ensure Successful Cell Line Development

September 11, 2024
Cell line development (CLD) is a cornerstone in the production of biologics, directly influencing the efficiency of the manufacturing process, the quality of the final product, and the overall success of a therapeutic program. However, the path to successful CLD isn’t always straightforward and can present many roadblocks if a drug developer isn’t aware of what to prioritize from the very start of